Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V (Open House Model)

Contrast Agent Cross-Agent Open-House Procedure for the Kv Region Berlin

Open Framework Agreement on Drug Discounts in Accordance with § 130A Paragraph 8 Sgb V with the Option to Join at any Time, So-Called Approval Model 2023-04

Conclusion of Non-Exclusive Discount Agreements According to § 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Formoterol Aclidinium Bromide

Conclusion of Non-Exclusive Discount Agreements According to § 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Dorzolamide (Multi-Dose Container, Preservative-Free)

Conclusion of Non-Exclusive Discount Agreements According to § 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Lenalidomide N3

Laboratory Supplies, Chemicals and Equipment 2023-2027 (Dps)

Conclusion of Non-Exclusive Discount Agreements According to §130A Paragraph 8 Sgb V for Various Active Ingredient(S)/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure

Conclusion of Non-Exclusive Discount Agreements According to § 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Solifenacin Tamsulosin

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.